Aortic arch calcification and clinical outcome in patients with end-stage renal disease

Kosaku Nitta1, Tetsuya Ogawa

  • 1Department of Medicine, Kidney Center, Tokyo Women's Medical University, Japan. knitta@kc.twmu.ac.jp

Insights

Vascular calcification is common in dialysis patients and linked to poor outcomes. A simple chest X-ray method can estimate aortic arch calcification, identifying high-risk patients for better cardiovascular event prevention.

Area of Science:

  • Nephrology
  • Cardiology
  • Radiology

Background:

  • Vascular calcification is prevalent in end-stage renal disease (ESRD) patients, particularly those on hemodialysis.
  • It significantly correlates with adverse prognosis and cardiovascular mortality in this population.
  • Pathogenesis involves vascular smooth muscle cell transformation and both traditional and non-traditional risk factors specific to dialysis patients.

Purpose of the Study:

  • To introduce and validate a simple, non-invasive method for estimating aortic arch calcification (AoAC) in hemodialysis patients.
  • To assess the correlation between AoAC scores from chest X-rays and multi-detector CT (MDCT) volumes.
  • To evaluate the association of AoAC with cardiovascular disease prevalence and cardiovascular mortality.

Main Methods:

  • Development and validation of a simple technique for estimating AoAC using chest X-ray.
  • Comparison of AoAC scores from chest X-ray with AoAC volume measured by MDCT (gold standard).
  • Analysis of the relationship between AoAC presence and cardiovascular disease prevalence, and Kaplan-Meier analysis for cardiovascular mortality.

Main Results:

  • A simple chest X-ray method provides a reliable estimation of AoAC.
  • The AoAC score derived from chest X-ray correlates well with AoAC volume measured by MDCT.
  • Presence of AoAC is linked to higher prevalence of cardiovascular diseases and increased cardiovascular mortality.

Conclusions:

  • Screening for AoAC using chest X-ray is a cost-effective and efficient method for identifying high-risk hemodialysis patients.
  • This screening can guide treatment strategies aimed at preventing vascular calcification and cardiovascular events.
  • Early identification of AoAC facilitates targeted interventions to improve outcomes in ESRD patients.

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...